Sign Up Today and Learn More About Aspect Biosystems Stock
Invest in or calculate the value of your shares in Aspect Biosystems or other pre-IPO companies through EquityZen's platform.
Aspect Biosystems Stock (ASPB)
Biotech company developing bioprinted tissue therapeutics to transform how we treat disease.
About Aspect Biosystems Stock
Founded
2013
Industries
Software, Artificial Intelligence, Data and Analytics
Aspect Biosystems Press Mentions
Stay in the know about the latest news on Aspect Biosystems
Aspect Biosystems receives funding for cellular medicine project
pharmaceutical-technology • Apr 07, 2026
Aspect Biosystems Garners Funding for Big Project Targeting Disease Solutions
techcouver • Apr 04, 2026
Feds invest $79 million in Aspect Biosystems to develop 3D-printed tissue treatment
betakit • Apr 03, 2026
Aspect Biosystems secures $79-million in federal funding to advance 3-D tissue printing technology
theglobeandmail • Apr 03, 2026
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines
pharmiweb • Apr 02, 2026
Aspect Biosystems Management
Leadership team at Aspect Biosystems
Co-founder & CEO
Tamer Mohamed
Co-founder & Chief Technology Officer
Simon Beyer
Join now and verify your accreditation status to gain access to:
- Aspect Biosystems Current Valuation
- Aspect Biosystems Stock Price
- Aspect Biosystems Management
- Available deals in Aspect Biosystems and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Aspect Biosystems Cap Table and Funding History by Share Class and Liquidity Preferences
- Aspect Biosystems Revenue and Financials
- Aspect Biosystems Highlights
- Aspect Biosystems Business Model
- Aspect Biosystems Risk Factors
- Aspect Biosystems Research Report from SACRA Research
Trading Aspect Biosystems Stock
How to invest in Aspect Biosystems stock?
Accredited investors can buy pre-IPO stock in companies like Aspect Biosystems through EquityZen funds. These investments are made available by existing Aspect Biosystems shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Aspect Biosystems stock?
Shareholders can sell their Aspect Biosystems stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
